Drug Profile
ZL 3101
Alternative Names: Fugan; ZL-3101Latest Information Update: 30 Mar 2021
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GlaxoSmithKline; ZAI Lab
- Class Anti-inflammatories; Antipsoriatics; Skin disorder therapies
- Mechanism of Action Cell movement inhibitors; Cytokine inhibitors; Inflammation mediator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Eczema; Psoriasis